PANTHERx®Rare Selected by Edenbridge as Specialty Pharmacy for Yargesa
01 Apr 2024 //
PR NEWSWIRE
Edenbridge Pharmaceuticals Names Douglas S. Boothe as CEO
20 Dec 2023 //
BUSINESSWIRE
Enforcement Report - Week of November 8, 2023
08 Nov 2023 //
FDA
Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT
28 Feb 2022 //
BUSINESSWIRE
Edenbridge Pharmaceuticals Announces U.S. FDA Approval of DARTISLA ODT
17 Dec 2021 //
BIOSPACE
FDA Approves Edenbridge`s DARTISLA ODT Orally Disintegrating Tablets
17 Dec 2021 //
BUSINESSWIRE